Company Overview

Update
Founded:
2005
Headquarters:
Irvine, CA
Funding:
$70.9M
Categories:
Biotechnology
Description:
Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.

Detailed Description

Update

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.

Current Team (5)

Update

Past Team (3)

Update
  • Gcaripuq15bbgn9no4sd

    William Biggs

    Director, Technical Operations
  • Gcaripuq15bbgn9no4sd

    William Biggs

    Director, Genetics & Genomics - Aviir Diagnostic Laboratories
  • 5c864cb5858a96a7a2393ece954b489f

    Ted McCluskey

    Chief Medical Officer, Vice President of Clinical
    Feb, 2008 - Dec, 2010

Board Members and Advisors (5)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    9805 Research Drive

    Irvine, CA 92618

    USA